Carboplatin

Sold as P & u carboplatin csv, Accord carboplatin, Aspen carboplatin, Trolintil, Asplata, Spalcarb, Carboplatin AURO, Claribop, Kemocarb, Carbosin

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 9
Registrations: 29
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Pfizer Laboratories (Pty) LtdCancelled	P & u carboplatin csv	150 mg / 15 ml, 450 mg / 45 ml	290501, 300310	S4	None
Accord Healthcare (Pty) Ltd	Accord carboplatin	10 mg/ml	410435	S4	None
Pharmacare limited û woodmead3 of 8 cancelled	Aspen carboplatin, Asplata	000 mg/100 ml 1, 50 mg, 50 mg/5 ml, 150 mg, 150 mg/15 ml, 450 mg, 450 mg/45 ml, 600 mg/60 ml	410608, 410609, 410610, 460066, 460067, 460068, 460069, 460076	S4	None
Trinity Pharma (Pty) Ltd	Trolintil	150 MG, 450 MG	420965, 420966	S4	None
Mc Pharma (Pty) LtdCertificate held by Ruby Pharmaceuticals (Pty) Ltd	Spalcarb	50, 150, 450	550434, 550435, 550436	S4	PI PIL
Aurogen South Africa (Pty) Ltd	Carboplatin AURO	50 mg/5 ml, 150 mg/15 ml, 450 mg/45 ml, 600 mg/60 ml	561218, 561219, 561220, 561221	S4	None
Hetero Drugs South Africa (Pty) Ltd	Claribop	50 mg/5 ml, 150 mg/15 ml, 450 mg/45 ml, 600 mg/60 ml	590294, 590295, 590296, 590297	S4	None
Cipla Medpro (Pty) Ltd	Kemocarb	150, 450	A380532, A380533	S4	None
Teva Pharmaceuticals (Pty) LtdCertificate held by Teva	Carbosin	150, 450, 600	A390170, Z0261, Z0262	S4	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
P & u carboplatin csv 150 MG / 15 ML injection EACH 1 ml SOLUTION CONTAINS CARBOPLATIN 10 mg	150 mg / 15 mlInjection	29050129/26/0501	Cancelled	S4	None
P & u carboplatin csv 450 MG / 45 ML injection EACH 1 ml CONTAINS CARBOPLATIN 10 mg	450 mg / 45 mlInjection	30031030/26/0310	Cancelled	S4	None
Accord carboplatin 10 mg/ml injection EACH 1,0 ml SOLUTION CONTAINS :CARBOPLATIN 10,0 mg	10 mg/mlInjection	41043541/26/0435	Registered	S4	None
Aspen carboplatin 50 MG EACH 5,0 ml VIAL CONTAINS CARBOPLATIN 50,0 mg	50 mg	41060841/26/0608	Cancelled	S4	None
Aspen carboplatin 150 MG EACH 15,0 ml VIAL CONTAINS CARBOPLATIN 150,0 mg	150 mg	41060941/26/0609	Cancelled	S4	None
Aspen carboplatin 450 MG EACH 45,0 ml VIAL CONTAINS CARBOPLATIN 450,0 mg	450 mg	41061041/26/0610	Cancelled	S4	None
Trolintil 150 MG EACH 15,0 ml VIAL CONTAINS CARBOPLATIN 150,0 mg	150 MG	42096542/26/0965	Registered	S4	None
Trolintil 450 MG EACH 45,0 ml VIAL CONTAINS CARBOPLATIN 450,0 mg	450 MG	42096642/26/0966	Registered	S4	None
Asplata 50 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS CARBOPLATIN 50,0 mg	50 mg/5 ml	46006646/26/0066	Registered	S4	None
Asplata 150 mg/15 ML EACH 15,0 ml SOLUTION CONTAINS CARBOPLATIN 150,0 mg	150 mg/15 ml	46006746/26/0067	Registered	S4	None
Asplata 600 mg/60 ML EACH 60,0 ml SOLUTION CONTAINS CARBOPLATIN 600,0 mg	600 mg/60 ml	46006846/26/0068	Registered	S4	None
Asplata 1 000 mg/100 ML EACH 100,0 ml SOLUTION CONTAINS CARBOPLATIN 1 000,0 mg	000 mg/100 ml 1	46006946/26/0069	Registered	S4	None
Asplata 450 mg/45 ML EACH 45,0 ml SOLUTION CONTAINS CARBOPLATIN 450,0 mg	450 mg/45 ml	46007646/26/0076	Registered	S4	None
Spalcarb 50 EACH 5,0 ml SOLUTION CONTAINS: CARBOPLATIN 50,0 mg	50Concentrate for solution for infusion	55043455/26/0434Approved 13 December 2022	Registered	S4	PI PIL
Spalcarb 150 EACH 5,0 ml SOLUTION CONTAINS: CARBOPLATIN 150,0 mg	150Concentrate for solution for infusion	55043555/26/0435Approved 13 December 2022	Registered	S4	PI PIL
Spalcarb 450 EACH 5,0 ml SOLUTION CONTAINS: CARBOPLATIN 450,0 mg	450Concentrate for solution for infusion	55043655/26/0436Approved 13 December 2022	Registered	S4	PI PIL
Carboplatin 50 mg/5 ML AURO EACH 5,0 ml SOLUTION CONTAINS: CARBOPLATIN 50,0 mg	50 mg/5 ml	56121856/26/1218	Registered	S4	None
Carboplatin 150 mg/15 ML AURO EACH 15,0 ml SOLUTION CONTAINS: CARBOPLATIN 150,0 mg	150 mg/15 ml	56121956/26/1219	Registered	S4	None
Carboplatin 450 mg/45 ML AURO EACH 45,0 ml SOLUTION CONTAINS: CARBOPLATIN 450,0 mg	450 mg/45 ml	56122056/26/1220	Registered	S4	None
Carboplatin 600 mg/60 ML AURO EACH 60,0 ml SOLUTION CONTAINS: CARBOPLATIN 600,0 mg	600 mg/60 ml	56122156/26/1221	Registered	S4	None
Claribop 50 mg/5 ML EACH VIAL CONTAINS: CARBOPLATIN 50,0 mg	50 mg/5 ml	59029459/26/0294	Registered	S4	None
Claribop 150 mg/15 ML EACH VIAL CONTAINS: CARBOPLATIN 150,0 mg	150 mg/15 ml	59029559/26/0295	Registered	S4	None
Claribop 450 mg/45 ML EACH VIAL CONTAINS: CARBOPLATIN 450,0 mg	450 mg/45 ml	59029659/26/0296	Registered	S4	None
Claribop 600 mg/60 ML EACH VIAL CONTAINS: CARBOPLATIN 600,0 mg	600 mg/60 ml	59029759/26/0297	Registered	S4	None
Kemocarb 150 EACH VIAL CONTAINS CARBOPLATIN 150,0 mg	150	A380532A38/26/0532	Registered	S4	None
Kemocarb 450 EACH VIAL CONTAINS CARBOPLATIN 450,0 mg	450	A380533A38/26/0533	Registered	S4	None
Carbosin 600 EACH 1,0 ml SOLUTION CONTAINS CARBOPLATIN 10,0 mg	600Injection	A390170A39/26/0170Approved 5 February 2016	Registered	S4	PI PIL
Carbosin 150 EACH 1 ml SOLUTION CONTAINS CARBOPLATIN 10 mg	150Injection	Z0261Z/26/261Approved 5 February 2016	Registered	S4	PI PIL
Carbosin 450 EACH 1 ml CONTAINS CARBOPLATIN 10 mg	450Injection	Z0262Z/26/262Approved 5 February 2016	Registered	S4	PI PIL

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Carboplatin

S4: Carboplatin
Consolidated Schedules 06 July 2026, line 5663

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Spalcarb 50, Mc Pharma (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsSpalcarb 50, Mc Pharma (Pty) Ltd Patient information leaflet (PIL)For patients and carersSpalcarb 50, Mc Pharma (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background